小児クリティカルケアの世界市場

小児クリティカルケアの世界市場は2030年までに368億米ドルに達する見込み

2024年に279億米ドルと推定される小児クリティカルケアの世界市場は、2024～2030年の分析期間においてCAGR 4.7%で成長し、2030年には368億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである呼吸器は、CAGR 6.5%を記録し、分析期間終了までに103億米ドルに達すると予測されます。その他分野の成長率は、分析期間中CAGR 3.3％と推定されます。

米国市場は76億米ドルと推定、中国はCAGR 8.9％で成長予測

米国の小児クリティカルケア市場は、2024年に76億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.9％を辿り、2030年までに78億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.8%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の小児クリティカルケア市場- 主要動向と促進要因のまとめ

小児クリティカルケアが現代医療における重要なフロンティアである理由とは？

小児クリティカルケアは、世界のヘルスケアにおいて最も資源集約的で、技術主導型の、医療的に複雑な専門分野の一つです。呼吸不全、敗血症、外傷性脳損傷、先天異常、心機能障害、大手術後の術後回復など、生命を脅かすような状態にある乳幼児、小児、青少年を集中的に監視し治療します。成人の集中治療室とは異なり、小児集中治療室（PICU）では、急速に変化する生理機能、臓器系の未熟さ、体重に応じた薬物投与量の大きな変動といった課題に対処しなければならないです。PICUでは通常、機械的人工呼吸器、体外膜酸素化療法（ECMO）、持続的腎代替療法（CRRT）、侵襲的血行動態モニタリング装置などの高度な生命維持管理システムが使用されるが、これらはすべて小児の生理機能に合わせて調整されています。重篤な小児患者の管理は、迅速な診断、年齢を調整した鎮静プロトコール、家族中心のケア原則の統合の必要性によってさらに複雑になっています。世界の動向は、未熟児の生存率の増加、小児外傷、先天性心疾患、慢性呼吸器疾患などにより、小児重症患者の負担が増加していることを示しています。このような臨床的重圧は、特に都市部の病院、大学医療センター、独立型の小児科施設において、PICU拡大の原動力となっています。専任の小児集中治療医や、薬剤師、呼吸療法士、栄養士、小児生活専門家などの学際的ケアチームの存在は、この分野の多次元的な性質を反映しています。クリティカルケアへの需要が高まるにつれ、小児部門は医療政策と病院インフラ計画の両方で最前線の優先事項として浮上しています。

技術の進歩は、小児集中治療室をどのように改革しているのか？

小児クリティカルケアの変革は、生命維持のための介入の精度、安全性、効率の向上を目指した急速な技術革新によって加速しています。新生児・小児用モードを備えた次世代人工呼吸器、ポータブルECMOシステム、統合患者モニタリングプラットフォームは、先進的なPICUの標準となりつつあります。これらのシステムは、リアルタイム分析、早期警告スコア、カスタマイズ可能なダッシュボードを提供し、集中治療医がデータに基づいた迅速な意思決定を行えるようにします。人工知能（AI）と予測分析は、特に敗血症や急性呼吸不全の症例において、臨床的に明らかになる前に患者の悪化を特定するためにますます使用されるようになっています。さらに、ベッドサイドでの超音波検査、血液ガス迅速分析装置、リアルタイム凝固モニターなどのポイントオブケア診断が、治療までの時間を短縮し、緊急事態における転帰を改善しています。ロボット工学や自動ドラッグデリバリーシステムもまた、クリティカルケアのワークフローで試験的に導入され、投薬ミスを減らし、特に血管圧迫薬や鎮静薬の注入速度を一定に保っています。ウェアラブルセンサーや遠隔測定ツールは、バイタルパラメータの継続的な遠隔モニタリングを可能にし、院内およびステップダウン環境での早期介入をサポートします。現在、多くのPICUが集中監視システムを導入しており、複数の患者のデータを一つの制御室で観察・管理できるようになっています。さらに、電子カルテ（EHR）、臨床判断支援ツール、投薬管理プラットフォームのデジタル統合により、業務の合理化、コンプライアンスの向上、冗長性の削減が実現しています。クラウドベースやAIで強化されたクリティカルケアエコシステムに投資する病院が増えていることから、将来のPICUは、応答性が向上するだけでなく、予測、個別化、プロトコル駆動型になると予想されます。

なぜケアモデルは集学的で家族中心のクリティカルケアへとシフトしているのか？

小児クリティカルケアの提供は、サイロ化した臨床的介入から、統合された集学的で家族を包括したケアモデルへとますますシフトしています。この進化の背景には、重症の小児は医学的治療と並行して情緒的、発達的、心理社会的ニーズに対処できる環境でよりよく回復するという認識があります。今日のPICUでは、集中治療専門医、看護師、ソーシャルワーカー、セラピスト、家族をケアに関する話し合いに参加させる共同回診を重視しています。これらのチームは、小児の長期的な転帰を考慮した治療計画を立案し、PICU退院後の認知的、感情的、身体的障害を含む小児科集中治療後症候群（PICS-p）のリスクを最小限に抑えるために協力しています。先天性心疾患、外傷性脳損傷、多臓器不全などの複雑な病態に対しては、専門的なケア・パスウェイが導入されつつあります。病院はまた、24時間体制で両親を受け入れ、ベッドサイドでのケアに家族が参加しやすくし、ストレスを軽減して発達の継続性をサポートするために、遊戯療法、音楽療法、教育を取り入れたインフラに投資しています。小児の鎮静と疼痛管理プロトコールは、非薬理学的戦略や有効な疼痛評価ツールの使用が増え、より微妙になってきています。低・中所得国では、構造化されたクリティカルケア教育プログラムと遠隔PICUの利用が増加し、小児クリティカルケアの専門知識のギャップを埋めつつあります。さらに、世界の医療機関は、クリティカルケア提供のベストプラクティスを保証するために、ケアバンドル、シミュレーショントレーニング、共同アウトカム登録を通じて標準化を推進しています。ケアモデルの全体的な転換は、臨床転帰だけでなく、若年患者とその家族の経験と満足度をも向上させています。

小児クリティカルケア市場の成長はいくつかの要因によって牽引されている...

小児クリティカルケア市場の成長は、技術革新、エンドユーズダイナミクスの進化、ヘルスケア提供における消費者の期待の変化に関連するいくつかの要因によって牽引されています。主な要因の1つは、新生児合併症、外傷、呼吸器感染症、先天性心疾患など、集中的なモニタリングと介入を必要とする小児重症疾患の発生率が増加していることです。画像診断、リアルタイム分析、小児特有の生命維持技術の進歩により、重症状態の早期発見とより的を絞った管理が可能になり、高度急性期小児医療環境への投資が促されています。最終用途の面では、病院や医療システムがPICUのキャパシティを拡大し、一般のICUを小児用に改修し、小児病院内に特殊なクリティカルケア棟を開発して、需要の高まりに対応しています。小児医療サービスを三次医療機関や四次医療機関に集中させる傾向が強まり、高度な重症医療を提供する地理的な拠点が形成されつつあります。同時に、小児搬送チーム、移動ECMOサービス、遠隔医療を利用した集中治療が台頭し、十分な医療が行き届いていない地域でもクリティカルケアへのアクセスが拡大しています。消費者の期待も重要な役割を果たしており、小児に特化した治療環境、治療方針の決定における透明性の向上、リアルタイムモニタリングへの参加などを求める家族の声が高まっています。これと並行して、教育、インフラの標準化、アウトカムのベンチマーキングを推進する世界のイニシアチブが、世界的にケアの質のベースラインを引き上げつつあります。さらに、機器メーカー、病院システム、研究機関の連携により、小児に特化した医療機器やデジタルプラットフォームの開発が加速しています。こうした複合的な要因が小児クリティカルケア市場の持続的な拡大を後押しし、高性能で思いやりのある小児ヘルスケアシステムの要としての役割を再定義しています。

セグメント

治療（呼吸器、循環器、神経、消化器、筋骨格系疾患、感染症、血液、先天性、多臓器不全症候群、その他）;病院の所有形態（公営／政府所有、非営利民間所有、営利民間所有）

調査対象企業の例

• Abbott Laboratories
• Advin Health Care
• Baxter International Inc.
• Becton, Dickinson and Company（BD）
• Boston Scientific Corporation
• Compumedics Limited
• Cook Medical
• David Medical Device Co., Ltd.
• Dixion distribution of medical devices GmbH
• Dragerwerk AG & Co. KGaA
• Fritz Stephan GmbH
• GE Healthcare
• Hamilton Medical
• ICU Medical Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Nexxspan Healthcare
• Nice Neotech Medical Systems Pvt. Ltd.
• Terumo Corporation
• TSE MEDICAL

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pediatric Critical Care Market to Reach US$36.8 Billion by 2030

The global market for Pediatric Critical Care estimated at US$27.9 Billion in the year 2024, is expected to reach US$36.8 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Respiratory, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.3 Billion by the end of the analysis period. Growth in the Others segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Pediatric Critical Care market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Pediatric Critical Care Market - Key Trends & Drivers Summarized

What Makes Pediatric Critical Care a High-Stakes Frontier in Modern Medicine?

Pediatric critical care represents one of the most resource-intensive, technology-driven, and medically complex specialties in global healthcare. It encompasses the intensive monitoring and treatment of infants, children, and adolescents with life-threatening conditions, including respiratory failure, sepsis, traumatic brain injuries, congenital anomalies, cardiac dysfunctions, and post-operative recovery after major surgeries. Unlike adult critical care, pediatric intensive care units (PICUs) must contend with rapidly changing physiology, organ system immaturity, and highly variable weight-based drug dosing-challenges that demand specialized equipment, tailored treatment protocols, and highly trained personnel. PICUs typically operate with advanced life-support systems such as mechanical ventilators, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapy (CRRT), and invasive hemodynamic monitoring devices, all calibrated for pediatric physiology. The management of critically ill pediatric patients is further complicated by the need for rapid diagnostics, age-adjusted sedation protocols, and the integration of family-centered care principles. Global trends show a rising burden of pediatric critical illnesses due to increased survival of premature infants, pediatric trauma, congenital heart disease, and chronic respiratory conditions. These clinical pressures are driving the expansion of PICUs, particularly in urban hospitals, academic medical centers, and standalone pediatric facilities. The presence of dedicated pediatric intensivists and interdisciplinary care teams-including pharmacists, respiratory therapists, nutritionists, and child life specialists-reflects the multidimensional nature of this field. As critical care demands escalate, the pediatric segment is emerging as a frontline priority in both health policy and hospital infrastructure planning.

How Are Technological Advancements Reinventing Pediatric Intensive Care Units?

The transformation of pediatric critical care is being accelerated by rapid technological innovation aimed at enhancing precision, safety, and efficiency in life-sustaining interventions. Next-generation ventilators with neonatal and pediatric modes, portable ECMO systems, and integrated patient monitoring platforms are becoming standard across advanced PICUs. These systems offer real-time analytics, early warning scores, and customizable dashboards that allow intensivists to make faster, data-driven decisions. Artificial intelligence (AI) and predictive analytics are being increasingly used to identify patient deterioration before it becomes clinically apparent, particularly in sepsis and acute respiratory failure cases. In addition, point-of-care diagnostics, such as bedside ultrasound, rapid blood gas analyzers, and real-time coagulation monitors, are shortening time-to-treatment and improving outcomes in emergency situations. Robotics and automated drug delivery systems are also being piloted in critical care workflows to reduce medication errors and ensure consistent infusion rates, especially for vasopressors and sedatives. Wearable sensors and telemetry tools allow continuous remote monitoring of vital parameters, supporting early intervention in both in-hospital and step-down settings. Many PICUs are now implementing centralized monitoring systems where data from multiple patients can be observed and managed from a single control room. Furthermore, the digital integration of electronic health records (EHRs), clinical decision support tools, and medication management platforms has streamlined operations, improved compliance, and reduced redundancies. With hospitals increasingly investing in cloud-based and AI-enhanced critical care ecosystems, the PICU of the future is expected to be not only more responsive but also predictive, personalized, and protocol-driven.

Why Are Care Models Shifting Toward Multidisciplinary and Family-Centered Critical Care?

The delivery of pediatric critical care is increasingly shifting from siloed clinical interventions to integrated, multidisciplinary, and family-inclusive care models. This evolution is driven by the recognition that critically ill children recover better in environments where emotional, developmental, and psychosocial needs are addressed alongside medical treatment. Today’s PICUs emphasize collaborative rounds that include intensivists, nurses, social workers, therapists, and family members in care discussions. These teams work collectively to design treatment plans that account for the child’s long-term outcomes, minimizing the risk of post-intensive care syndrome in pediatrics (PICS-p), which includes cognitive, emotional, and physical impairments after PICU discharge. Specialized care pathways are being implemented for complex conditions such as congenital heart defects, traumatic brain injuries, and multi-organ failure, all requiring synchronized efforts from various specialists. Hospitals are also investing in infrastructure that accommodates parents around the clock, facilitates family participation in bedside care, and incorporates play therapy, music therapy, and education to reduce stress and support developmental continuity. Pediatric sedation and pain management protocols are becoming more nuanced, with greater use of non-pharmacological strategies and validated pain assessment tools. In low- and middle-income countries, the rise of structured critical care education programs and the use of tele-PICUs are bridging the gap in pediatric critical care expertise. Moreover, global health organizations are promoting standardization through care bundles, simulation training, and collaborative outcome registries to ensure best practices in critical care delivery. The holistic shift in care models is enhancing not only clinical outcomes but also the experience and satisfaction of both young patients and their families.

The Growth in the Pediatric Critical Care Market Is Driven by Several Factors…

The growth in the pediatric critical care market is driven by several factors related to technological innovation, evolving end-use dynamics, and shifting consumer expectations in healthcare delivery. One of the primary drivers is the increasing incidence of pediatric critical illnesses, including neonatal complications, traumatic injuries, respiratory infections, and congenital heart conditions, all of which require intensive monitoring and intervention. Advances in diagnostic imaging, real-time analytics, and pediatric-specific life-support technologies are enabling earlier recognition and more targeted management of critical conditions, prompting investments in high-acuity pediatric care settings. On the end-use front, hospitals and health systems are expanding their PICU capacities, retrofitting general ICUs for pediatric use, and developing specialized critical care wings within children’s hospitals to meet rising demand. The growing trend of centralizing pediatric services in tertiary and quaternary care institutions is creating geographic hubs for advanced critical care delivery. Simultaneously, the rise of pediatric transport teams, mobile ECMO services, and telemedicine-enabled intensive care is extending access to critical care in underserved regions. Consumer expectations are also playing a key role, with families increasingly advocating for child-specific care environments, greater transparency in treatment decisions, and involvement in real-time monitoring. In parallel, global initiatives promoting pediatric critical care education, infrastructure standardization, and outcome benchmarking are raising the baseline for care quality worldwide. Furthermore, collaborations between device manufacturers, hospital systems, and research institutions are accelerating the development of pediatric-focused medical equipment and digital platforms. These combined factors are fueling a sustained expansion of the pediatric critical care market and redefining its role as a cornerstone of high-performance, compassionate pediatric healthcare systems.

SCOPE OF STUDY:

The report analyzes the Pediatric Critical Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Respiratory, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital, Multiple organ dysfunction syndrome, Others); Hospital Ownership (Publicly / Government-owned, Not-for-profit privately owned, For-profit privately owned)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Advin Health Care
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Boston Scientific Corporation
• Compumedics Limited
• Cook Medical
• David Medical Device Co., Ltd.
• Dixion distribution of medical devices GmbH
• Dragerwerk AG & Co. KGaA
• Fritz Stephan GmbH
• GE Healthcare
• Hamilton Medical
• ICU Medical Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Nexxspan Healthcare
• Nice Neotech Medical Systems Pvt. Ltd.
• Terumo Corporation
• TSE MEDICAL

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Pediatric Critical Care - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Severe Neonatal and Pediatric Conditions Propels Growth in Critical Care Infrastructure
  • Expansion of Pediatric Intensive Care Units (PICUs) Strengthens Business Case for Advanced Equipment
  • Increasing Availability of Pediatric Ventilators and Monitors Drives Technological Integration
  • Surge in Complex Pediatric Surgeries Throws the Spotlight on Perioperative Critical Care Needs
  • Improved Survival Rates Among Preterm Infants Accelerates Demand for Long-Term Intensive Support
  • Growing Burden of Pediatric Trauma and Acute Infections Sustains Demand for Critical Care Beds
  • Development of Specialized Pediatric Emergency Transport Systems Expands Access to Intensive Services
  • Integration of AI in Critical Care Monitoring Enhances Decision Support and Predictive Analytics
  • Proliferation of Pediatric ECMO Programs Drives Adoption of Advanced Life Support Technologies
  • Emphasis on Family-Centered Critical Care Models Strengthens Patient Outcomes and Facility Ratings
  • Increased Staffing of Pediatric Intensivists Spurs Efficiency and Quality of ICU Services
  • Rising Use of Smart Alarms and Automation Reduces Alert Fatigue in Pediatric ICUs
  • Growth in Pediatric Tele-ICU Programs Extends Reach of Critical Expertise to Remote Regions
  • Advancements in Non-Invasive Hemodynamic Monitoring Propel Precision in Pediatric Care Delivery
  • Expansion of Critical Care Training and Fellowship Programs Drives Workforce Readiness
  • Public Health Crises such as Pandemics Highlight Systemic Gaps and Spur Infrastructure Expansion
  • Innovations in Pediatric Sedation and Pain Management Enhance Comfort and Recovery Outcomes
  • Government Funding for Pediatric Health Systems Accelerates Procurement of ICU-Grade Equipment
  • Focus on Infection Control in Critical Settings Fuels Demand for Antimicrobial Surfaces and PPE
  • International Collaborations and Standardization Efforts Improve Quality and Consistency of Pediatric ICU Care
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pediatric Critical Care Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pediatric Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Musculoskeletal conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Musculoskeletal conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Musculoskeletal conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Infection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Congenital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Congenital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Congenital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Multiple organ dysfunction syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Multiple organ dysfunction syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Multiple organ dysfunction syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Publicly / Government-owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Publicly / Government-owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Publicly / Government-owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Not-for-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Not-for-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Not-for-profit privately owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for For-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for For-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for For-profit privately owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• JAPAN
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• CHINA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• EUROPE
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Pediatric Critical Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• FRANCE
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• GERMANY
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 95: UK Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: UK 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 101: Spain Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Spain Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Spain 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 104: Spain Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Spain Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Spain 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 107: Russia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Russia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Russia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 110: Russia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Russia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Russia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of Europe Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Rest of Europe 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Pediatric Critical Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 128: Australia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Australia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Australia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 131: Australia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Australia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Australia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• INDIA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 134: India Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: India Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: India 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 137: India Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: India Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: India 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 140: South Korea Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: South Korea Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: South Korea 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 143: South Korea Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: South Korea Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: South Korea 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Asia-Pacific Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Asia-Pacific Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Pediatric Critical Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Latin America Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Latin America 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Latin America Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Latin America 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 161: Argentina Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Argentina Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Argentina 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 164: Argentina Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Argentina Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Argentina 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 167: Brazil Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Brazil Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Brazil 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 170: Brazil Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Brazil Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Brazil 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 173: Mexico Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Mexico Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Mexico 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 176: Mexico Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Mexico Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Mexico 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Latin America Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Latin America 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Latin America Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Latin America 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Pediatric Critical Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 188: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Middle East Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Middle East 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 191: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Middle East Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Middle East 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 194: Iran Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Iran Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Iran 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 197: Iran Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Iran Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Iran 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 200: Israel Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Israel Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Israel 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 203: Israel Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Israel Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Israel 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Saudi Arabia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Saudi Arabia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Saudi Arabia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Saudi Arabia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 212: UAE Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UAE Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UAE 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 215: UAE Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: UAE Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: UAE 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Middle East Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Middle East 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Middle East Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Middle East 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• AFRICA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 224: Africa Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Africa Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Africa 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 227: Africa Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Africa Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Africa 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030

IV. COMPETITION